top of page
About
Our Company
Our Leadership Team
Science
Our Technology
DNA Methylation
Exosomes
Products
Our Portfolio
Laboratory Developed Tests Services
Eye Care
Clinical Trial Drug Distribution
Health Supplements
Pipeline
Newsroom
Contact
Investors
More
Use tab to navigate through the menu items.
Newsroom
All Posts
Publication
News
Leadership Story
From Stamp Trading to Nasdaq: The Journey of Dr. Ethan Shen
3 days ago
YD Bio and EG BioMed Launch Nationwide Telehealth Platform to Expand Cancer Detection Services in the U.S.
Apr 2
YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem
Mar 25
YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform
Feb 27
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy
Feb 5
YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development
Jan 9
bottom of page
